Health alert as Cruise Ship battles deadly hantavirus outbreak

The World Health Organization (WHO) has issued an alert following a cluster of severe respiratory illnesses, including two confirmed cases of hantavirus and three fatalities, aboard a cruise ship traversing the South Atlantic.

The outbreak, first reported on May 2, 2026, has prompted a coordinated international public health response to contain the rare but deadly disease.

Situation Overview

The Dutch-flagged vessel, carrying 147 passengers and crew of 23 nationalities, reported the cluster of illnesses to the WHO.


As of May 4, 2026, seven cases have been identified two laboratory- confirmed hantavirus infections and five suspected cases.

Tragically, three individuals have died, one patient remains critically ill in intensive care, and three others are experiencing mild symptoms.

The illness, characterized by fever, gastrointestinal issues, and rapid progression to pneumonia, acute respiratory distress syndrome, and shock, had an onset period between April 6 and April 28, 2026.
Voyage and Potential Exposure

The cruise ship departed Ushuaia, Argentina, on April 1, 2026, embarking on an itinerary that included stops in remote and ecologically diverse regions such as mainland Antarctica, South Georgia, Nightingale Island, Tristan da Cunha, Saint Helena, and Ascension Island.

The exact source of exposure remains under investigation, with authorities exploring potential contact with local wildlife either during the voyage or prior to boarding in Argentina.

The vessel is currently moored off the coast of Cabo Verde, where medical teams are evaluating remaining suspected cases.
Case Summaries

• Case 1: An adult male developed symptoms on April 6, 2026, and rapidly deteriorated, dying on board on April 11. No microbiological tests were performed at the time.

• Case 2: An adult female, a close contact of Case 1, developed gastrointestinal
symptoms and died on April 26, after medical evacuation to South Africa. Hantavirus infection was confirmed by PCR on May 4, 2026. Contact tracing for flight passengers is underway.

• Case 3: An adult male presented with febrile illness and pneumonia on April 24, 2026. He was medically evacuated to South Africa and is currently in ICU, with hantavirus infection confirmed by PCR on May 2, 2026.
• Case 4: An adult female, with symptom onset on April 28, died on May 2, 2026, due to pneumonia.

Coordinated Public Health Response

Authorities from Cabo Verde, the Netherlands, Spain, South Africa, and the United Kingdom are engaged in a multi- national response.

Key actions include:

• Timely information sharing and coordination among National International Health Regulations (IHR) Focal Points.
• Advising onboard passengers to practice maximal physical distancing and remain in their cabins.

• Ongoing epidemiological investigations to determine the source of exposure.
• Sharing passenger and crew lists with respective countries for contact tracing.

• Support for clinical management and medical evacuation of symptomatic passengers.
• Laboratory testing and confirmation of hantavirus infection by the National Institute for Communicable Diseases (NICD) of South Africa, with additional samples sent to Institut Pasteur de Dakar, Senegal.

Understanding Hantavirus

Hantavirus cardiopulmonary syndrome (HCPS), or hantavirus pulmonary syndrome (HPS), is a zoonotic viral respiratory disease caused by hantaviruses from the Orthohantavirus
genus.

It is primarily transmitted to humans through contact with the urine, feces, or saliva of infected rodents, or by touching contaminated surfaces. While rare, it can be deadly.
Symptoms typically appear 2-4 weeks post-exposure, ranging from flu-like symptoms to rapid onset of severe respiratory distress and hypotension.

Although uncommon, limited human-to -human transmission has been reported in previous outbreaks of Andes virus, a
specific species of hantavirus.

WHO Risk Assessment

The WHO currently assesses the risk to the global population from this event as low, while the health body continues to monitor the epidemiological situation and will update its risk assessment as new information becomes available.

Oluwaseun Sonde: Managing Editor, a renowned journalist with multitask functionality and a member of the Association of Corporate Online Editor (ACOE). Email: admin@mediabypassnews.com
Related Post